Biotech firm Synthego files for bankruptcy despite a purchase agreement with Perceptive Advisors and plans for operational ...

This spring, New York's Chelsea Gallery District becomes the launch pad for a dystopian spectacle masquerading as a campaign ...

New York's Chelsea Gallery District becomes the launch pad for a dystopian spectacle masquerading as a campaign rollout. "Opposing Visions: The Trump Era in Art" unveils its provocative centerpiece: ...

Everlaw, the cloud-native investigation and litigation platform, today announced Adams & Reese, a nationally recognized AmLaw 200 firm, has chosen Everlaw as its exclusive ediscovery solution to ...

So, here we are, launching our fourth edition of Fierce Biotech's layoff tracker. As always, if you know of a layoff occurring at a biotech, please reach out to the Fierce Biotech editorial team ...

LONDON (Reuters) -Some U.S. biotech companies are considering moving early-stage trials of new medicines outside the United States as worry grows that layoffs and policy changes at the drugs ...

Greetings and welcome to the PDS Biotech first quarter in 2025 earnings conference call. (operator Instructions) As a reminder, this conference is being recorded. It is now my pleasure to ...

Several hundred job cuts will affect Bay Area workers in the tech, biotech, energy and school sectors, according to official state filings. Bay Area bounces back with job gains, with warnings ...

Developed by Biovet, a subsidiary of Bharat Biotech, BIOLUMPIVAXIN addresses a serious challenge the animal husbandry sector faces, offering a great relief to farmers. Lumpy skin disease (LSD ...

May 16 (UPI) --Danish drugmaker Novo Nordisk is teaming up with California-based biotech Septerna to develop new pills to treat obesity, type 2 diabetes and other metabolic diseases. The deal ...

SINGAPORE - Singapore biotech firm Mirxes launched its initial public offering (IPO) in Hong Kong on May 15, aiming to raise HK$1.09 billion (S$181 million) to support stronger growth in the ...

FDA Upheaval Pushes Some Biotech Firms to Plan Early Trials Out of US By Maggie Fick LONDON (Reuters) -Some U.S. biotech companies are considering moving early-stage trials of new medicines ...